Free Trial
NASDAQ:SSKN

Strata Skin Sciences (SSKN) Stock Price, News & Analysis

Strata Skin Sciences logo
$1.77 +0.02 (+1.14%)
Closing price 08/22/2025 03:17 PM Eastern
Extended Trading
$1.74 -0.03 (-1.69%)
As of 08/22/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Strata Skin Sciences Stock (NASDAQ:SSKN)

Key Stats

Today's Range
$1.67
$1.76
50-Day Range
$1.75
$2.58
52-Week Range
$1.67
$3.79
Volume
18,214 shs
Average Volume
14,999 shs
Market Capitalization
$7.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Buy

Company Overview

Strata Skin Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

SSKN MarketRank™: 

Strata Skin Sciences scored higher than 52% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Strata Skin Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Strata Skin Sciences has received no research coverage in the past 90 days.

  • Read more about Strata Skin Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Strata Skin Sciences are expected to grow in the coming year, from ($1.05) to ($1.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Strata Skin Sciences is -0.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Strata Skin Sciences is -0.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Strata Skin Sciences has a P/B Ratio of 25.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.68% of the float of Strata Skin Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Strata Skin Sciences has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Strata Skin Sciences has recently increased by 554.55%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Strata Skin Sciences does not currently pay a dividend.

  • Dividend Growth

    Strata Skin Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.68% of the float of Strata Skin Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Strata Skin Sciences has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Strata Skin Sciences has recently increased by 554.55%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Strata Skin Sciences has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Strata Skin Sciences this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Strata Skin Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.00% of the stock of Strata Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 32.43% of the stock of Strata Skin Sciences is held by institutions.

  • Read more about Strata Skin Sciences' insider trading history.
Receive SSKN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Strata Skin Sciences and its competitors with MarketBeat's FREE daily newsletter.

SSKN Stock News Headlines

Strata Skin Sciences Faces Nasdaq Compliance Notice
This stock could leave NVDA in the dust
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel
See More Headlines

SSKN Stock Analysis - Frequently Asked Questions

Strata Skin Sciences' stock was trading at $2.91 on January 1st, 2025. Since then, SSKN shares have decreased by 39.2% and is now trading at $1.77.

Strata Skin Sciences, Inc. (NASDAQ:SSKN) released its earnings results on Wednesday, August, 13th. The medical device company reported ($0.60) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by $0.33. The medical device company had revenue of $7.70 million for the quarter, compared to analysts' expectations of $8.56 million. Strata Skin Sciences had a negative net margin of 35.13% and a negative trailing twelve-month return on equity of 266.94%.
Read the conference call transcript
.

Strata Skin Sciences's stock reverse split on the morning of Friday, June 7th 2024.The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Strata Skin Sciences investors own include Amarin (AMRN), AbbVie (ABBV), OPKO Health (OPK), AT&T (T), Agile Therapeutics (AGRX), Advanced Micro Devices (AMD) and Avino Silver & Gold Mines (ASM).

Company Calendar

Last Earnings
8/13/2025
Today
8/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SSKN
CIK
1051514
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$6.00
Low Price Target
$6.00
Potential Upside/Downside
+239.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.84)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.09 million
Net Margins
-35.13%
Pretax Margin
-35.65%
Return on Equity
-266.94%
Return on Assets
-32.66%

Debt

Debt-to-Equity Ratio
49.58
Current Ratio
0.98
Quick Ratio
0.87

Sales & Book Value

Annual Sales
$33.56 million
Price / Sales
0.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.07 per share
Price / Book
25.29

Miscellaneous

Outstanding Shares
4,170,000
Free Float
2,544,000
Market Cap
$7.38 million
Optionable
Not Optionable
Beta
0.66

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:SSKN) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners